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Almost all commentators accept that the United Kingdom poor
performance in cancer is genuine. (Coleman et al, 2011) Of more
interest is why this should be so; in particular, how much of the
problem rests in diagnostic delay? The evidence for diagnostic
delay includes poor 1-year mortality (Morris et al, 2011), a high
number of general practice consultations before diagnosis
(Lyratzopoulos et al, 2012), and the inverse relationship between
the strength of primary care and cancer survival (Vedsted and
Olesen, 2011). It is also important to unpick the components of
diagnostic delay, as each has different solutions. Delay in seeking
medical care can be combated by awareness campaigns; delays in
primary care could be tackled by education or enhanced provision
of investigations; hospital delays are generally countered by
improved organisation of services. Many of these have been tried,
with some progress (Health, 2011).
Two papers in this issue examine another marker of possible
diagnostic delay – emergency admissions. The first (Elliss-Brookes
et al, 2012) deftly merges data from several sources to identify the
proportion of cancer patients diagnosed as an emergency. The
second (Bottle et al, 2012) examines patient and general practice
factors to explain differences in these emergency admission
proportions. Both start from the position that emergency
admissions – with their higher mortality – may be a failure of
the diagnostic process, and may be preventable. If so, then
emergency admission proportions could be used as a proxy for
quality of the cancer diagnostic process. Better still, emergency
admission data are collected routinely, and the algorithms used in
Elliss-Brookes et al (2012) can be repeated, so could give us a
reasonably fast moving indicator of any progress in cancer
diagnosis.
Interpretation of emergency admission proportions is not
simple. Emergency admissions are defined with respect to time,
and not necessarily by severity of the patient’s overall condition,
though these may overlap. There is a considerable difference
between leukaemia being discovered on a routine blood count, and
a patient with bowel obstruction complicating colon cancer. Both
patients will generally be admitted to hospital immediately – and
be classified as emergencies. Most patients with leukaemia have
pallor, fatigue, with perhaps easy bruising, and as long as a blood
count is performed reasonably swiftly, no diagnostic improvement
is possible. Conversely, the second patient has more than just
cancer – he has a complication of the cancer. This may have been a
diagnostic failure, in that most patients with such emergencies
have described a probable symptom of their cancer to their GP
before diagnosis (Cleary et al, 2007). However, it may be the first
presentation of the illness, or the patient may already have been
referred for investigation when the crisis arose. These three
possibilities are all amenable to improvement – but the method of
improvement will be different for each one. Even so, colorectal
emergencies are probably a reasonable proxy for diagnostic
underperformance, albeit a crude one. This is not the case at a
practice level, however, because the small number of cancer
diagnoses in any one practice in a year makes sensible
interpretation of cancer diagnostic metrics – including the
emergency admission proportion – almost impossible. In any
case, the main associations between emergencies and practice
characteristics seen in Bottle et al (2012) – patient age, ethnicity,
and deprivation – are hardly amenable to change.
It is attractive to rank cancers in order of diagnostic under-
performance, allowing particular cancers to be prioritised for
intervention: both papers make much of the differences between
cancers. This may again be the nature of the beast. There is an
marked disparity between breast cancer, with emergency admis-
sion proportions in the two papers of 4 and 5%, and cerebral
tumours at 49 and 62% (as a side issue, these different figures show
how important different definitions and methodologies are). Both
cancers are dominated by a main symptom – breast lump and
headache. The risk of a cancer with a breast lump is high, perhaps
8% (Barton et al, 1999), so GPs are encourage to refer all women
with breast problems, to ensure all those with cancer are identified
swiftly. The very low emergency admission proportion suggests
this policy works – at considerable cost, of course (Hamilton,
2008). In contrast, the risk of a brain tumour with a new onset
headache presented to general practice is B0.09% (Hamilton and
Kernick, 2007) so a policy of investigating everyone with new
headache would not only overwhelm services, CT scanning could
generate more cancers than the lives saved (Hamilton and
Roobottom, 2012). GPs have to identify which patients with
headache have additional symptoms, and select them for scanning,
which is now available directly for GPs (Department of Health,
2012). This is an inexact science: is it any surprise that many
patients are diagnosed after a seizure, and thus as an emergency?
However, like colorectal cancer, emergency admissions may be a
reasonable proxy for speed of diagnosis of brain tumours (and if
they fall once the open access MRI scheme matures, this will be
welcomed) but they will surely never remotely approach the
proportion seen in breast cancer.
Mortality is higher in patients presenting with emergencies.
Again, we must be cautious in attributing all the higher mortality
to the emergency itself. Some may be ‘reverse causation,’ whereby
patients with advanced cancer at first presentation are rapidly
identified and hospitalised. These so-called ‘sick-quick’ had a high
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inherent mortality anyway. This may partly explain the waiting
time paradox, where short times to diagnosis have a higher
mortality (Torring et al, 2011). This does not mean that emergency
admissions should be ignored – more that the potential mortality
benefit from a reduction may be less than hoped.
Overall, some emergency admissions are preventable by earlier
diagnosis. Thus, the slow fall in the proportion of emergency
admissions in the United Kingdom is good news (National Cancer
Intelligence Network, 2012). However, the measure is a crude
proxy for quality of the diagnostic process, and certainly too
crude to be used at a local level. It is also of very limited value in
comparisons across cancer sites. Its greatest value will be in
monitoring the effect of initiatives targeting a single cancer site
over time.
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